CytomX Therapeutics, Inc.

NASDAQ:CTMX

1.17 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 25.11541.46326.60726.38424.72423.4990.94616.91518.16517.13619.72717.58716.28815.97116.37317.78816.60849.5938.27910.7129.01329.48511.47112.50921.33814.18427.07324.1448.75211.6536.2723.4543.0942.2231.9881.9392.0431.7421.8611.9150.6660.635
Cost of Revenue 0.4590.4670.4861.4261.5321.4961.4891.4851.45401.4830000000000000000000000000000000
Gross Profit 24.65640.99626.12124.95823.19222.003-0.54315.4316.71117.13618.24417.58716.28815.97116.37317.78816.60849.5938.27910.7129.01329.48511.47112.50921.33814.18427.07324.1448.75211.6536.2723.4543.0942.2231.9881.9392.0431.7421.8611.9150.6660.635
Gross Profit Ratio 0.9820.9890.9820.9460.9380.936-0.5740.9120.9210.9251111111111111111111111111111111
Reseach & Development Expenses 24.7521.62118.93716.44820.67121.17519.56430.36731.15930.55936.57929.14326.122.37122.00724.04924.06642.81436.44127.96730.83536.37628.30627.54925.55322.45820.70428.9228.07614.57615.34813.33712.70513.3659.5039.1575.0334.6644.3393.9164.00616.041
General & Administrative Expenses 8.3957.7547.8276.8137.4017.97710.06710.4911.74810.5439.45611.0859.3939.2279.1458.6348.689.5729.2178.4639.4119.6748.9758.1379.0427.3567.6166.2496.0495.6915.1545.0334.6475.044.0094.0512.5521.9462.1811.4631.4551.441
Selling & Marketing Expenses -0.037-0.036-0.037000000000000000000000000000000000000000
SG&A 8.3587.7187.796.8137.4017.97710.06710.4911.74810.5439.45611.0859.3939.2279.1458.6348.689.5729.2178.4639.4119.6748.9758.1379.0427.3567.6166.2496.0495.6915.1545.0334.6475.044.0094.0512.5521.9462.1811.4631.4551.441
Other Expenses -0.002-0.0110.009-0.007-0.0470.0150.0010.030.2960.0130.007-0.013-0.0820.005-0.028-0.0150.0050.012-0.0090.022-0.088-0.061-0.0180.0290.061-0.140.074-0.047-0.1740.12-0.0230.045-0.110.019-0.026-0.287-0.18-1.251-0.011-0.0100
Operating Expenses 33.10829.33926.72723.26128.07229.15229.63140.85742.90741.10246.03540.22835.49331.59831.15232.68332.74652.38645.65836.4340.24646.0537.28135.68634.59529.81428.3235.16934.12520.26720.50218.3717.35218.40513.51213.2087.5856.616.525.3795.47117.506
Operating Income -8.45211.657-0.6063.123-3.348-5.653-28.685-23.942-24.742-23.966-26.308-22.641-19.205-15.627-14.779-14.895-16.138-2.793-37.379-25.718-31.233-16.565-25.81-23.177-13.257-15.63-1.247-11.025-25.373-8.614-14.23-14.916-14.258-16.182-11.524-11.269-5.542-4.868-4.659-3.464-4.795-16.847
Operating Income Ratio -0.3370.281-0.0230.118-0.135-0.241-30.322-1.415-1.362-1.399-1.334-1.287-1.179-0.978-0.903-0.837-0.972-0.056-4.515-2.401-3.465-0.562-2.25-1.853-0.621-1.102-0.046-0.457-2.899-0.739-2.269-4.318-4.608-7.279-5.797-5.812-2.713-2.794-2.503-1.809-7.2-26.531
Total Other Income Expenses Net 1.9692.1832.5122.692-0.0472.3420.7330.6460.5580.0810.007-0.013-0.0820.005-0.028-0.0150.0050.012-0.0090.022-0.088-0.061-0.0180.0290.061-0.140.074-0.047-0.1740.12-0.0230.045-0.110.019-0.026-0.287-0.18-1.251-0.011-0.01-0.135-0.157
Income Before Tax -6.48313.841.9065.815-1.087-3.311-27.952-23.296-24.184-23.885-26.228-22.584-19.243-15.554-14.701-14.71-15.679-1.706-35.877-23.699-28.96-14.13-23.321-20.929-11.656-14.3950.101-10.266-25.19-8.258-14.059-14.661-14.173-16.026-11.485-11.867-5.801-6.211-4.777-3.589-4.93-17.004
Income Before Tax Ratio -0.2580.3340.0720.22-0.044-0.141-29.548-1.377-1.331-1.394-1.33-1.284-1.181-0.974-0.898-0.827-0.944-0.034-4.333-2.212-3.213-0.479-2.033-1.673-0.546-1.0150.004-0.425-2.878-0.709-2.242-4.245-4.581-7.209-5.777-6.12-2.839-3.565-2.567-1.874-7.402-26.778
Income Tax Expense 0.0510.0491.0692.823-2.308-2.342-1.372-0.646-0.558-0.081-0.073-0.07-0.044-0.068-0.106-0.2-0.454-13.911-0.421-1.997-2.361-0.0068.9122.5021.7911.098-0.52-0.0190.026-0.001-0.0260.0010.0030.0030.0020.0030.005-1.0210.010.1071.151.051
Net Income -6.53413.7910.8372.992-1.087-0.969-26.58-22.65-23.626-23.804-26.228-22.584-19.243-15.554-14.701-14.71-15.67912.205-35.456-23.699-28.96-14.124-32.233-23.431-13.447-15.4930.621-10.247-25.216-8.257-14.033-14.662-14.176-16.029-11.487-11.87-5.806-6.211-4.787-3.589-6.08-18.055
Net Income Ratio -0.260.3330.0310.113-0.044-0.041-28.097-1.339-1.301-1.389-1.33-1.284-1.181-0.974-0.898-0.827-0.9440.246-4.283-2.212-3.213-0.479-2.81-1.873-0.63-1.0920.023-0.424-2.881-0.709-2.237-4.245-4.582-7.211-5.778-6.122-2.842-3.565-2.572-1.874-9.129-28.433
EPS -0.0770.170.0120.037-0.016-0.015-0.4-0.34-0.36-0.36-0.4-0.35-0.3-0.26-0.32-0.32-0.340.27-0.78-0.52-0.64-0.31-0.72-0.53-0.35-0.40.016-0.28-0.69-0.23-0.39-0.4-0.39-0.44-0.32-0.34-0.17-0.18-0.14-0.1-6.63-18.26
EPS Diluted -0.0770.170.0120.037-0.016-0.015-0.4-0.34-0.36-0.36-0.4-0.35-0.3-0.26-0.32-0.32-0.340.26-0.78-0.52-0.64-0.31-0.71-0.53-0.35-0.40.016-0.28-0.69-0.23-0.38-0.4-0.39-0.44-0.32-0.34-0.17-0.18-0.14-0.1-6.63-18.26
EBITDA -7.99312.124-0.123.123-2.738-5.058-28.077-23.319-24.132-23.364-25.633-21.961-18.528-14.953-14.117-14.243-15.516-2.156-37.379-25.041-30.566-15.912-25.311-22.667-12.794-15.218-0.843-10.548-25.004-7.657-13.18-13.736-13.263-15.318-10.78-11.149-5.091-5.713-4.447-3.276-4.604-16.672
EBITDA Ratio -0.3180.292-0.0050.118-0.111-0.215-29.68-1.379-1.328-1.363-1.299-1.249-1.138-0.936-0.862-0.801-0.934-0.043-4.515-2.338-3.391-0.54-2.207-1.812-0.6-1.073-0.031-0.437-2.857-0.657-2.101-3.977-4.287-6.891-5.423-5.75-2.492-3.28-2.39-1.711-6.913-26.255